BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6656882)

  • 21. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.
    Fahrlander PD; Sümegi J; Yang JQ; Wiener F; Marcu KB; Klein G
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3746-50. PubMed ID: 2987943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse c-mos oncogene activation is prevented by upstream sequences.
    Wood TG; McGeady ML; Baroudy BM; Blair DG; Vande Woude GF
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7817-21. PubMed ID: 6096859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic cyclophosphamide resistance in mouse myeloma hybridomas.
    Frondoza CG; DiSanto JP; Humphrey RL
    Hybridoma; 1988 Aug; 7(4):397-405. PubMed ID: 3169807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants.
    Weiland E; Thiel HJ
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1863-72. PubMed ID: 2993478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A; Huleihel M; Segal S; Apte RN
    Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The possible role of cellular genes related to retroviruses in the process of chemical and radiation carcinogenesis.
    Weinstein IB; Gattoni-Celli S; Kirschmeier P; Dina D
    Princess Takamatsu Symp; 1982; 12():139-51. PubMed ID: 6897728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.
    Marcu KB; Harris LJ; Stanton LW; Erikson J; Watt R; Croce CM
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):519-23. PubMed ID: 6188153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene.
    Kuff EL; Feenstra A; Lueders K; Rechavi G; Givol D; Canaani E
    Nature; 1983 Apr; 302(5908):547-8. PubMed ID: 6835385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA sequences involved in the rearrangement and expression of the murine c-myc gene.
    Dunnick W; Baumgartner J; Fradkin L; Schultz C
    Curr Top Microbiol Immunol; 1984; 113():154-60. PubMed ID: 6478863
    [No Abstract]   [Full Text] [Related]  

  • 32. [Morphocytochemical and electron microscopic research on murine hybridoma cells producing and not producing monoclonal antibodies].
    Sidorenko SP; Gluzman DF; Vetrova EP; Iurchenko OV; Berdova AG
    Tsitologiia; 1988 Jan; 30(1):39-43. PubMed ID: 3358281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum-free medium for growth factor-dependent and -independent plasmacytomas and hybridomas.
    Shacter E
    J Immunol Methods; 1987 May; 99(2):259-70. PubMed ID: 3584996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
    Alkan SS; Mestel F; Jiricka J; Blaser K
    Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells.
    Ochi A; Hawley RG; Hawley T; Shulman MJ; Traunecker A; Köhler G; Hozumi N
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6351-5. PubMed ID: 6312453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybridomas derived from lipopolysaccharide-activated anti-mu-treated B cells have active suppression of IgM secretion, demonstrable by secondary fusion.
    Lawton AR; Summerlin VS; Dooley JS
    J Immunol; 1990 Nov; 145(10):3177-80. PubMed ID: 2230114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
    Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
    Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Karyotypic characteristics of a number of clonal lines of an interspecific mouse-mink hybridoma].
    Glazko TT
    Tsitologiia; 1988 May; 30(5):597-605. PubMed ID: 3176172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.